Astec LifeSciences announces rights issue of equity shares

Astec LifeSciences Limited (BSE: 533138) has announced a proposed rights issue of up to 28,01,673 equity shares. The shares have a face value of INR10.00 each and will be offered at an issue price of INR890.00 per share. This rights issue could potentially generate approximately INR249.35 Crore for the company. The rights issue will be available to eligible equity shareholders in the ratio of 1 rights equity share for every 7 fully paid-up equity shares held as of the record date, Friday, July 4, 2025. The company's Rights Issue Committee approved the Letter of Offer on July 2, 2025, which will be filed with BSE Limited, National Stock Exchange of India Limited, and the Securities and Exchange Board of India. The Letter of Offer is available on the company's website.